Activation of the angiotensin II type I receptor by a nonpeptide agonist. [PDF]
Skiba MA +12 more
europepmc +1 more source
Clinical Pharmacology of the Angiotensin Receptor Antagonists [PDF]
openaire +2 more sources
This archived document is maintained by the Oregon State Library as part of the Oregon Documents Depository Program. It is for informational purposes and may not be suitable for legal purposes.Title from PDF caption (viewed on May 31, 2012)"Updated 12 ...
core
Redefining Therapeutic Targets in Hypertension and Cardiometabolic Syndrome. [PDF]
Masenga SK, Kirabo A.
europepmc +1 more source
WONOEP appraisal: Biomarkers and treatment strategies beyond the synapse
Abstract Epilepsy is a heterogeneous neurological disorder affecting more than 70 million people worldwide, posing significant challenges for clinicians due to its complex etiology, diverse manifestations, variable treatment responses, and the inability to predict seizures or disease onset reliably.
Mirte Scheper +11 more
wiley +1 more source
Emerging Strategies for Cardio-Renal Protection Beyond RAAS Blockade: <i>Emphasis on Non-diabetic CKD and Resistant Hypertension</i>. [PDF]
Alrashidi FS.
europepmc +1 more source
(A) Mount number, (B) mount latency, (C) intromission number, and (D) intromission latency are the parameters of sexual behavior. Met = metformin. D100 = 100 Donkwa. D90G10 = 90% Donkwa + 10% Goron‐Tula. D85G15 = 85% Donkwa + 15% Goron‐Tula. D80G20 = 80% Donkwa + 20% Goron‐Tula. The mean ± standard error of the mean (SEM) expressed the results. *Values
O. T. Mamukuyomi +2 more
wiley +1 more source
Effects of heart failure pharmacotherapy on natriuresis and diuresis: A narrative review. [PDF]
Jankowiak B, Ponikowski P, Biegus J.
europepmc +1 more source
Illuminating point‐of‐care diagnostics with aggregation‐induced emission biosensors
This review highlights the application of aggregation‐induced emission luminogens (AIEgens) in point‐of‐care (POC) diagnostics for disease biomarker detection. It systematically examines a range of biosensing platforms, including lateral flow immunoassays, microfluidic chips, and electrochemiluminescence sensors, alongside their utility in detecting ...
Danni Hu +3 more
wiley +1 more source
Early mineralocorticoid receptor antagonism for end-organ protection in hypertension: Implications for disparities and rethinking the timing paradigm. [PDF]
Ezeugwu CO.
europepmc +1 more source

